Litcius/Paper detail

Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells

Ching‐Hsuan Liu, Chen‐Jei Tai, Yu‐Ting Kuo, Shen‐Shong Chang, Liang Lin

2023Viruses10 citationsDOIOpen Access PDF

Abstract

Hepatocellular carcinoma (HCC) remains a difficult-to-treat cancer due to late diagnosis and limited curative treatment options. Developing more effective therapeutic strategies is essential for the management of HCC. Oncolytic virotherapy is a novel treatment modality for cancers, and its combination with small molecules merits further exploration. In this study, we combined oncolytic measles virus (MV) with the natural triterpenoid compound ursolic acid (UA) and evaluated their combination effect against HCC cells, including those harboring hepatitis B virus (HBV) or hepatitis C virus (HCV) replication. We found that the combination of MV and UA synergistically induced more cell death in Huh-7 HCC cells through enhanced apoptosis. In addition, increased oxidative stress and loss of mitochondrial potential were observed in the treated cells, indicating dysregulation of the mitochondria-dependent pathway. Similar synergistic cytotoxic effects were also found in HCC cells harboring HBV or HCV genomes. These findings underscore the potential of oncolytic MV and UA combination for further development as a treatment strategy for HCC.

Topics & Concepts

Oncolytic virusHepatocellular carcinomaVirotherapyMeasles virusHepatitis B virusCancer researchApoptosisUrsolic acidHepatitis C virusVirologyLiver cancerCancer cellCombination therapyCancerVirusMedicineBiologyMeaslesVaccinationPharmacologyInternal medicineBotanyBiochemistryVirus-based gene therapy researchHerpesvirus Infections and Treatmentsinterferon and immune responses
Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells | Litcius